DEGRADOMER
Live / Registered — Registered — Section 8 accepted (as of 08 Oct 2025)
What this means for you
Registered since 05 Nov 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88125997
- Registration number
- 5900541
- Mark type
- Stylized text
- Filed
- 20 Sept 2018
- Published for opposition
- 20 Aug 2019
- Registered
- 05 Nov 2019
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
Owner
- Trilo Therapeutics, Inc., Piedmont, CA, US
- Trilo Therapeutics, Inc., Belmont, CA, US
- Trilo Therapeutics, Inc., Belmont, CA, US
Prosecution history
- 08 Oct 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
- 08 Oct 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED
- 06 Oct 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 18 Jun 2025 — TEAS SECTION 8 RECEIVED
- 05 Nov 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 05 Nov 2019 — REGISTERED-PRINCIPAL REGISTER
- 20 Aug 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 20 Aug 2019 — PUBLISHED FOR OPPOSITION
- 31 Jul 2019 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 12 Jul 2019 — ASSIGNED TO LIE
- 02 Jul 2019 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 21 Jun 2019 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 20 Jun 2019 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 20 Jun 2019 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 07 Jan 2019 — NOTIFICATION OF NON-FINAL ACTION E-MAILED